Factors other than the HLA – match might have an impact on transplant outcomes. New studies showed that genomic factors

Following renal transplantation, patients are at risk of developing a wide range of complications. These may include hematological disorders, including

Many patients develop chronic kidney disease (CKD) after acute kidney injury (AKI). The risk of CKD increases more than eight-fold

Many patients with the rare kidney disease FSGS require dialysis in the course of the d i s e a

Due to the immunological pathogenesis of IgA nephropathy (IgAN), patients used to be given immunosuppressive therapy; however, this was shown

C3 glomerulopathy is a rare disease in which the deposition of C3 protein causes severe inflammation of the glomeruli, which

Neprilysin inhibition (NEPi) combined with a reninangiotensin system (RAS) blocker has been shown to play an important role among patients

Hyponatremia is associated with aggravation of inflammation in COVID-19 patients. However, to the best of our knowledge, no study has

Tolvaptan was approved to treat autosomal dominant polycystic kidney disease (ADPKD) to slow the rate of kidney growth and renal

Tolvaptan (TV) slows down the increase in total kidney volume (TKV) in patients with autosomal dominant polycystic kidney disease (ADPKD).